https://www.selleckchem.com/mTOR.html
A high number of patients who are hospitalized with COVID-19 develop acute respiratory distress syndrome (ARDS). In response to the need for clinical decision support tools to help manage the next pandemic during the early stages (ie, when limited labeled data are present), we developed machine learning algorithms that use semisupervised learning (SSL) techniques to predict ARDS development in general and COVID-19 populations based on limited labeled data. SSL techniques were applied to 29,127 encounters with patients who were admitted to 7 US hosp
Curtir
Comentario
Compartilhar
